Form 4 for IOVA IOVANCE BIOTHERAPEUTICS, INC.
Accepted 2024-02-20 00:00:00 ET · period of report 2024-02-20 · accession 0001104659-24-025539 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-20 | 2024-02-20 | IOVA | Dukes Iain D. | Dir | P - Purchase | $9.15 | +32.0K | 54.0K | +145% | +$292.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-20 | P | A | 32,000 | $9.15 | 54,000 | D | — | — | (F1) Such shares purchased pursuant to Issuer's underwritten offering, which priced on 02/20/2024. |